التفاصيل البيبلوغرافية
| العنوان: |
FP04.01 Nivolumab 480 mg Every 4 Weeks as De Novo Second-line Treatment for Advanced Non-Small Cell Lung Cancer: CheckMate 907 |
| المؤلفون: |
Toru Kumagai, A. Alexandru, Michael Schenker, Yuichiro Ohe, P. Ruff, M. Nishio, A. Tomiak, P. Lowry, I. Gore, I. Ntambwe, J. Rothenstein, Toyoaki Hida, Natasha B. Leighl, S. Marimuthu |
| المصدر: |
Journal of Thoracic Oncology. 16:S949-S950 |
| بيانات النشر: |
Elsevier BV, 2021. |
| سنة النشر: |
2021 |
| مصطلحات موضوعية: |
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Second line treatment, business.industry, Checkmate, medicine.disease, Internal medicine, medicine, Non small cell, Nivolumab, Lung cancer, business |
| تدمد: |
1556-0864 |
| URL الوصول: |
https://explore.openaire.eu/search/publication?articleId=doi_________::0d5f944efee83b8fe21f74f98ab75147
https://doi.org/10.1016/j.jtho.2021.08.215 |
| حقوق: |
CLOSED |
| رقم الأكسشن: |
edsair.doi...........0d5f944efee83b8fe21f74f98ab75147 |
| قاعدة البيانات: |
OpenAIRE |
